Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8TDQ0: Variant p.Tyr82Cys

Hepatitis A virus cellular receptor 2
Gene: HAVCR2
Feedback?
Variant information Variant position: help 82 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tyrosine (Y) to Cysteine (C) at position 82 (Y82C, p.Tyr82Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SPTCL; results in dysregulated secretion of inflammatory cytokines by macrophages; affects protein folding; decreased localization at the cell membrane. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 82 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 301 The length of the canonical sequence.
Location on the sequence: help ECGNVVLRTDERDVNYWTSR Y WLNGDFRKGDVSLTIENVTL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         ECGNVVLRTDERDVNY-WTSRYWLNGDFRKGDVSLTIENVTL

Mouse                         QCTNELLRTDERNVTYQKSSRYQLKGDLNKGDVSLIIKNVT

Rat                           QCASVVLRTDETNVTYRKSRRYQLKGNFYKGDMSLTIKNVT
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 22 – 301 Hepatitis A virus cellular receptor 2
Topological domain 22 – 202 Extracellular
Domain 22 – 124 Ig-like V-type
Disulfide bond 38 – 110
Disulfide bond 58 – 109
Beta strand 81 – 84



Literature citations
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden T.; Sepulveda F.E.; Khuong-Quang D.A.; Pratt J.; Valera E.T.; Garrigue A.; Kelso S.; Sicheri F.; Mikael L.G.; Hamel N.; Bajic A.; Dali R.; Deshmukh S.; Dervovic D.; Schramek D.; Guerin F.; Taipale M.; Nikbakht H.; Majewski J.; Moshous D.; Charlebois J.; Abish S.; Bole-Feysot C.; Nitschke P.; Bader-Meunier B.; Mitchell D.; Thieblemont C.; Battistella M.; Gravel S.; Nguyen V.H.; Conyers R.; Diana J.S.; McCormack C.; Prince H.M.; Besnard M.; Blanche S.; Ekert P.G.; Fraitag S.; Foulkes W.D.; Fischer A.; Neven B.; Michonneau D.; de Saint Basile G.; Jabado N.;
Nat. Genet. 50:1650-1657(2018)
Cited for: INVOLVEMENT IN SPTCL; SUBCELLULAR LOCATION; VARIANTS SPTCL CYS-82 AND MET-97; CHARACTERIZATION OF VARIANTS SPTCL CYS-82 AND MET-97; Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.
Polprasert C.; Takeuchi Y.; Kakiuchi N.; Yoshida K.; Assanasen T.; Sitthi W.; Bunworasate U.; Pirunsarn A.; Wudhikarn K.; Lawasut P.; Uaprasert N.; Kongkiatkamon S.; Moonla C.; Sanada M.; Akita N.; Takeda J.; Fujii Y.; Suzuki H.; Nannya Y.; Shiraishi Y.; Chiba K.; Tanaka H.; Miyano S.; Rojnuckarin P.; Ogawa S.; Makishima H.;
Blood Adv. 3:588-595(2019)
Cited for: INVOLVEMENT IN SPTCL; VARIANTS SPTCL CYS-82 AND ILE-101;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.